title: Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.
authors.forename: Edward L
authors.initials: EL
authors.lastname: Trimble
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Abrams
authors.forename: Sherry S
authors.initials: SS
authors.lastname: Ansher
authors.forename: Malcolm A
authors.initials: MA
authors.lastname: Smith
authors.forename: James A
authors.initials: JA
authors.lastname: Zwiebel
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Tomaszewski
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D006801:Humans; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D014481:United States
chemical_list: D000970:Antineoplastic Agents